These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12472494)

  • 1. Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodesiccation-curettage in a private dermatological practice.
    Werlinger KD; Upton G; Moore AY
    Dermatol Surg; 2002 Dec; 28(12):1138-42; discussion 1142. PubMed ID: 12472494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer.
    Chiller K; Passaro D; McCalmont T; Vin-Christian K
    Arch Dermatol; 2000 Nov; 136(11):1327-32. PubMed ID: 11074693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmelanoma skin cancer of the head and neck: surgical treatment.
    Akcam TM; Gubisch W; Unlu H
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):455-71. PubMed ID: 23084298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curettage-electrodesiccation treatment of basal cell carcinomas.
    Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
    Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chren MM; Linos E; Torres JS; Stuart SE; Parvataneni R; Boscardin WJ
    J Invest Dermatol; 2013 May; 133(5):1188-96. PubMed ID: 23190903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curettage and shave excision. A tissue-saving technic for primary cutaneous carcinoma worthy of inclusion in graduate training programs.
    Brooks NA
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 1):279-84. PubMed ID: 6715596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmelanoma skin cancers and infection with the human immunodeficiency virus.
    Lobo DV; Chu P; Grekin RC; Berger TG
    Arch Dermatol; 1992 May; 128(5):623-7. PubMed ID: 1575523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
    Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic.
    Chren MM; Sahay AP; Sands LP; Maddock L; Lindquist K; Bertenthal D; Bacchetti P
    Med Care; 2004 Oct; 42(10):1019-26. PubMed ID: 15377935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation.
    de Graaf YG; Basdew VR; van Zwan-Kralt N; Willemze R; Bavinck JN
    Br J Dermatol; 2006 Mar; 154(3):493-7. PubMed ID: 16445781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?
    Spencer JM; Tannenbaum A; Sloan L; Amonette RA
    Dermatol Surg; 1997 Aug; 23(8):625-30; discussion 630-1. PubMed ID: 9256908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The evaluation of tumor histopathology, location, characteristic, size and thickness of nonmelanoma skin cancers of the head and neck].
    Eskiizmir G; Ozgür E; Temiz P; Gençoğlan G; Ermertcan AT
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(2):91-8. PubMed ID: 22548266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
    Talbot S; Hitchcock B
    N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.
    Rowe DE; Carroll RJ; Day CL
    J Dermatol Surg Oncol; 1989 Apr; 15(4):424-31. PubMed ID: 2925988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects and therapy of skin malignancies in the head and neck area].
    Ermanni D; Grossenbacher R
    HNO; 1992 Sep; 40(9):331-3. PubMed ID: 1399710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the activity of skin tumor's excision in dermatology (France, 2009)].
    Thuny C; Bacconnier D; Berbis J; Auquier P; Egasse D; Amici JM; Berbis P
    Ann Dermatol Venereol; 2011 Feb; 138(2):100-6. PubMed ID: 21333819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study.
    Chren MM; Torres JS; Stuart SE; Bertenthal D; Labrador RJ; Boscardin WJ
    Arch Dermatol; 2011 May; 147(5):540-6. PubMed ID: 21576572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin tumours in white South Africans. Part V. Treatment of skin tumours.
    Whiting DA
    S Afr Med J; 1978 Feb; 53(5):166-70. PubMed ID: 653496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.